Skin Brightening Antiperspirant Deodorant Roll-on
FDA Label NDC 68828-199

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Jafra Cosmetics International for the product Skin Brightening Antiperspirant Deodorant Roll-on (NDC 68828-199). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding otc - active ingredient, otc - purpose, otc - keep out of reach of children, indications & usage, warnings, dosage & administration, inactive ingredient, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Otc - Active Ingredient

Active ingredients                          Purpose

Aluminum Chlorohydrate 12.3%      Antiperspirant

Otc - Purpose

Uses

reduces underarm wetness

Otc - Keep Out Of Reach Of Children

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Indications & Usage

Stop use if rash or irritation occurs

Warnings

Warnings

For external use only

Do not use on broken skin

Ask a doctor before before use if you have kidney disease

Dosage & Administration

Directions

Apply to underarms only

Inactive Ingredient

Water/Aqua, PEG-40 Stearate, PEG-25 Propylene Glycol Stearate, Cetyl Alcohol, Magnesium Aluminum Silicate, Sorbitan Sesquioleate, Fragrance/parfum, Phenoxyethanol, Ehtylhexylhexyl Glycerin, Mica, Titanium Dioxide/CI 77891, Azadirachta Indica Extract, Curcuma Longa, Hemisdesmus Indicus, Sphaeranthus Indicus Extract, Phyllanthus Emblica Extract

Package Label.Principal Display Panel

Jafra

Daily

Skin Brightening

antiperspirant deodorant roll-on

60 ml 2 FL OZ

Carton (Dayn 041ucdailybrighteningroll Onusa)

Carton (Dayn 041ucdailybrighteningroll Onusa)

* Please review the disclaimer below.